CVE-2026-10173Orthanc Explorer 2 URL StudyList.vue cross site scripting
Updated under an hour ago ()
Does this affect you?
It affects Orthanc Explorer 2. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 0.28%, higher than 19% of scored CVEs.
Do this next
Free account, 1 product
A weakness has been identified in Orthanc Explorer 2 up to 1.12.0. The impacted element is an unknown function of the file WebApplication/src/components/StudyList.vue of the component URL Handler. This manipulation of the argument remote-source causes cross site scripting. It is possible to initiate the attack remotely. The exploit has been made available to the public and could be used for attacks. Patch name: 21f78ce5da668bf5233efcd1896ec7c6e3b22eae. Applying a patch is the recommended action to fix this issue.
- CVSS
- 4.3 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N/E:P/RL:O/RC:C
- Weakness (CWE)
- CWE-79, CWE-94
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 0.28% (percentile 19)
- Assigned by
- VulDB
- NVD analysis
- Deferred
- Record last updated
- Jun 1, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
Orthanc Explorer 2 orthanc:explorer_2 | 1.0; 1.1; 1.2; 1.3; 1.4; 1.5; 1.6; 1.7; and 5 more ranges | CNA record |
References
- https://vuldb.com/vuln/367430vdb-entry, technical-description
- https://vuldb.com/vuln/367430/ctisignature, permissions-required
- https://vuldb.com/cve/CVE-2026-10173third-party-advisory
- https://vuldb.com/submit/819559third-party-advisory
- https://github.com/orthanc-server/orthanc-explorer-2/issues/108exploit, issue-tracking
- https://github.com/rafaelsouzars/orthanc-explorer-2/commit/21f78ce5da668bf5233efcd1896ec7c6e3b22eaepatch
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.